Here are what the editors at HealthDay consider to be the most important developments in Allergy for November 2006. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Anticonvulsant-Sensitive Patients Can React to Tricyclics
THURSDAY, Nov. 30 (HealthDay News) -- Patients with carbamazepine- and phenytoin-induced anticonvulsant hypersensitivity syndrome are at risk of having a reaction if treated with tricyclic antidepressant drugs, according to a study published in the November issue of the Annals of Allergy, Asthma & Immunology.
Abstract
Full Text (subscription or payment may be required)
Bee-Pollen Seen As Risky for Allergy Patients
THURSDAY, Nov. 30 (HealthDay News) -- Although often used as an alternative medicine or food supplement, bee-pollen usage by atopic patients could be dangerous, researchers report in the November issue of the Annals of Allergy, Asthma & Immunology.
Abstract
Full Text (subscription or payment may be required)
Atopy a Risk Factor for Ocular Herpes Disease
THURSDAY, Nov. 30 (HealthDay News) -- Atopic disease -- and especially severe atopy -- is a risk factor for ocular herpes simplex virus disease, according to a report in the November issue of the American Journal of Ophthalmology.
Abstract
Full Text (subscription or payment may be required)
Fluticasone May Improve Eosinophilic Esophagitis
TUESDAY, Nov. 28 (HealthDay News) -- Oral doses of fluticasone propionate can reduce symptoms and promote histologic remission in pediatric patients with eosinophilic esophagitis, according to the results of a randomized, double-blind and placebo-controlled trial published in the November issue of Gastroenterology.
Abstract
Full Text (subscription or payment may be required)
Editorial
Atopic Eczema Patients Often Sensitized to Yeast Strain
MONDAY, Nov. 27 (HealthDay News) -- About half of patients with atopic eczema have a sensitivity to the yeast Malassezia sympodialis, according to a report in the November issue of the Journal of Investigative Dermatology.
Abstract
Full Text (subscription or payment may be required)
Perceived Asthma Control Reduces Emergency Visits
FRIDAY, Nov. 17 (HealthDay News) -- Asthma patients who feel more in control of their asthma have better health and quality of life and are less likely to visit the emergency department or be hospitalized for asthma, according to study findings published in the November issue of Chest.
Abstract
Full Text
Regular Smoking in Childhood Linked to Asthma
THURSDAY, Nov. 16 (HealthDay News) -- Children and adolescents who report regular smoking have a nearly fourfold risk for developing asthma, according to a report in the Nov. 15 issue of the American Journal of Respiratory and Critical Care Medicine.
Abstract
Full Text (subscription or payment may be required)
Persistent Dermatitis Related to Egg Sensitivity
WEDNESDAY, Nov. 8 (HealthDay News) -- While most children eventually outgrow atopic dermatitis, children with an early sensitivity to eggs are more likely to have persistent atopic dermatitis than those with other types of allergy, researchers report in the November issue of the Journal of the American Academy of Dermatology. What's more, such children are also at greater risk of developing asthma and rhinoconjunctivitis by adolescence or young adulthood.
Abstract
Full Text (subscription or payment may be required)
FDA Issues Guidelines for Rhinosinusitis Research
FRIDAY, Nov. 3 (HealthDay News) -- The U.S. Food and Drug Administration has issued the first set of guidelines for researchers conducting clinical trials of chronic rhinosinusitis treatments. "Rhinosinusitis: Developing Guidance for Clinical Trials" will be published in a November supplement of the Journal of Allergy and Clinical Immunology and in Otolaryngology - Head and Neck Surgery.
Abstract
Full Text
